Unknown

Dataset Information

Bridging preclinical and clinical gut microbiota research using the ex vivo SIFR® technology.


ABSTRACT:

Introduction

While modulation of the human adult gut microbiota is a trending strategy to improve health, the underlying mechanisms are poorly understood.

Methods

This study aimed to assess the predictive value of the ex vivo, reactor-based, high-throughput SIFR® (Systemic Intestinal Fermentation Research) technology for clinical findings using three structurally different prebiotics [inulin (IN), resistant dextrin (RD) and 2'-fucosyllactose (2'FL)].

Results

The key finding was that data obtained within 1-2 days were predictive for clinical findings upon repeated prebiotic intake over weeks: among hundreds of microbes, IN stimulated Bifidobacteriaceae, RD boosted Parabacteroides distasonis, while 2'FL specifically increased Bifidobac

SUBMITTER: Van den Abbeele P 

PROVIDER: S-EPMC10178071 | biostudies-literature | 2023

REPOSITORIES: biostudies-literature